PharmiWeb.com - Global Pharma News & Resources
14-Jan-2019

SERNIVO Drug Profile, 2019 - Patents, Clinical Trials, Drug Prices, Annual Sales Revenues and Raw API Sources - ResearchAndMarkets.com

The "SERNIVO Drug Profile, 2019" report has been added to ResearchAndMarkets.com's offering.

SERNIVO Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs. The report focuses on SERNIVO and covers the following critical aspects of this drug:

  • United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Topics Covered

  • Profile for SERNIVO
  • US Patents
  • US Regulatory Exclusivity
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • International (ex US) Patents
  • Drug Prices - Average Pharmacy Cost
  • Drug Prices - Best Wholesale Price
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources

Companies Featured

  • Promius Pharma Llc
  • Novoseek
  • Tci (Tokyo Chemical Industry)
  • Molport
  • Abi Chem
  • Timtec
  • Chemmol
  • Abblis Chemicals
  • Akos Consulting & Solutions
  • Chembase.Cn
  • Key Organics/Bionet
  • Wolves R&D Chemical
  • An Pharmatech
  • Race Chemical
  • Targetmol
  • Clearsynth
  • Changzhou Highassay Chemical Co. Ltd
  • Acorn Pharmatech
  • Phion Ltd
  • Parchem
  • Apexbio Technology
  • Chem-Space.com Database
  • LGC Standards
  • Medchemexpress Mce
  • Selleckchem
  • Abachemscene
  • Chemieliva Pharmaceutical Co. Ltd
  • Ichemical Technology USA Inc
  • Musechem
  • Bld Pharm

For more information about this report visit https://www.researchandmarkets.com/research/wkkflg/sernivo_drug?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20190114005421/en/

Editor Details

Last Updated: 14-Jan-2019